Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers
Authors
Keywords
-
Journal
EXPERIMENTAL AND MOLECULAR MEDICINE
Volume 51, Issue 9, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-24
DOI
10.1038/s12276-019-0308-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic Therapy for Advanced Hepatocellular Carcinoma in an Evolving Landscape
- (2019) Kabir Mody et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions
- (2019) Jing Zhu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond
- (2019) Masatoshi Kudo WORLD JOURNAL OF GASTROENTEROLOGY
- The anti-tumor effect of regorafenib in lung squamous cell carcinoma in vitro
- (2018) Xiu Hu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice
- (2018) Mao-Chi Weng et al. BIOSCIENCE REPORTS
- Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review
- (2018) Maria Røed Skårderud et al. CANCER TREATMENT REVIEWS
- Effects of liver-targeted drugs on expression of immune-related proteins in hepatocellular carcinoma cells
- (2018) Meng-jun Qiu et al. CLINICA CHIMICA ACTA
- Regorafenib in the treatment of metastatic colorectal cancer
- (2018) Christelle de la Fouchardière Future Oncology
- Novel approaches for molecular targeted therapy against hepatocellular carcinoma
- (2018) Yuji Eso et al. HEPATOLOGY RESEARCH
- New Trends in the Therapeutic Approach to Metastatic Colorectal Cancer
- (2018) Julia Sánchez-Gundín et al. International Journal of Medical Sciences
- Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells
- (2018) Maria Refolo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regorafenib suppresses colon tumorigenesis and the generation of drug resistant cancer stem-like cells via modulation of miR-34a associated signaling
- (2018) Mao-Hua Cai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib
- (2018) Man Tong et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- FGFR2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers in vitro
- (2018) Yongjun Cha et al. Molecular Oncology
- Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma
- (2018) Anna Tutusaus et al. Oncotarget
- Metformin Enhances the Effect of Regorafenib and Inhibits Recurrence and Metastasis of Hepatic Carcinoma After Liver Resection via Regulating Expression of Hypoxia Inducible Factors 2α (HIF-2α) and 30 kDa HIV Tat-Interacting Protein (TIP30)
- (2018) Qing Yang et al. MEDICAL SCIENCE MONITOR
- Advances and Challenges on Management of Gastrointestinal Stromal Tumors
- (2018) Lin Mei et al. Frontiers in Oncology
- Molecularly targeted anti-cancer drugs inhibit the invasion and metastasis of hepatocellular carcinoma by regulating the expression of MMP and TIMP gene families
- (2018) Xiao-xiao He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Neratinib augments the lethality of [regorafenib + sildenafil]
- (2018) Laurence Booth et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice
- (2018) Tanios Bekaii-Saab et al. Clinical Colorectal Cancer
- Oleanolic Acid Inhibits Epithelial–Mesenchymal Transition of Hepatocellular Carcinoma by Promoting iNOS Dimerization
- (2018) Hongzhi Wang et al. MOLECULAR CANCER THERAPEUTICS
- Regorafenib reverses HGF-induced sorafenib resistance by inhibiting epithelial-mesenchymal transition in hepatocellular carcinoma
- (2018) Weibo Chen et al. FEBS Open Bio
- Systemic Therapy for Hepatocellular Carcinoma: Latest Advances
- (2018) Masatoshi Kudo Cancers
- Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma
- (2018) Ruiqi Liu et al. CANCER LETTERS
- Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer
- (2018) Yun-Kai Zhang et al. CANCER LETTERS
- Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells
- (2017) Marcus Tuchen et al. EUROPEAN JOURNAL OF CANCER
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathway
- (2017) Xiao-Lin Lin et al. PLoS One
- Management of Gastrointestinal Stromal Tumors
- (2017) Emily Z. Keung et al. SURGICAL CLINICS OF NORTH AMERICA
- Current research and treatment for gastrointestinal stromal tumors
- (2017) Kheng Tian Lim et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Present and future of metastatic colorectal cancer treatment: A review of new candidate targets
- (2017) Giulia Martini et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Regorafenib diminishes the expression and secretion of angiogenesis and metastasis associated proteins and inhibits cell invasion via NF-κB inactivation in SK-Hep1 cells
- (2017) Yu-Chang Liu et al. Oncology Letters
- Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
- (2017) Maria Kissel et al. Oncotarget
- Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
- (2017) Valentina Belli et al. Oncotarget
- IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines
- (2017) Maria Grazia Refolo et al. Oncotarget
- A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug
- (2017) Chen Chen et al. Scientific Reports
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma
- (2016) Hidehiko Takigawa et al. CANCER SCIENCE
- Effects of the multikinase inhibitors Sorafenib and Regorafenib in PTEN deficient neoplasias
- (2016) Cristina Mirantes et al. EUROPEAN JOURNAL OF CANCER
- Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-γ-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2
- (2016) Yi Xu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells
- (2016) YUKIE YOSHII et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy
- (2016) Néstor Prieto-Domínguez et al. JOURNAL OF PINEAL RESEARCH
- Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells
- (2016) Jai-Jen Tsai et al. ONCOLOGY REPORTS
- Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinib
- (2016) Johanna Falkenhorst et al. Oncotarget
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy
- (2015) Eric I. Marks et al. CANCER BIOLOGY & THERAPY
- Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab
- (2015) S. Napolitano et al. CLINICAL CANCER RESEARCH
- Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
- (2015) Hung Huynh et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Jin Li et al. LANCET ONCOLOGY
- Colorectal cancer
- (2015) Ernst J. Kuipers et al. Nature Reviews Disease Primers
- Inhibition of proliferation and migration of luminal and claudin-low breast cancer cells by PDGFR inhibitors
- (2014) Leanne Stalker et al. Cancer Cell International
- STAT3 Mediates Regorafenib-Induced Apoptosis in Hepatocellular Carcinoma
- (2014) W.-T. Tai et al. CLINICAL CANCER RESEARCH
- Regorafenib Inhibits Colorectal Tumor Growth through PUMA-Mediated Apoptosis
- (2014) D. Chen et al. CLINICAL CANCER RESEARCH
- Regorafenib for treatment of advanced gastrointestinal stromal tumors
- (2014) Lindsay C Overton et al. EXPERT OPINION ON PHARMACOTHERAPY
- Biological and Molecular Effects of Small Molecule Kinase Inhibitors on Low-Passage Human Colorectal Cancer Cell Lines
- (2014) Falko Lange et al. Biomed Research International
- Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy
- (2014) Danielle Ferraro et al. Therapeutic Advances in Medical Oncology
- Gastrointestinal Stromal Tumors
- (2013) Markku Miettinen et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells
- (2013) Erika Martinelli et al. INTERNATIONAL JOURNAL OF CANCER
- Regorafenib (BAY 73-4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer
- (2013) Roberta Schmieder et al. INTERNATIONAL JOURNAL OF CANCER
- Colorectal cancer
- (2013) Hermann Brenner et al. LANCET
- Regorafenib Inhibits Growth, Angiogenesis, and Metastasis in a Highly Aggressive, Orthotopic Colon Cancer Model
- (2013) L. Abou-Elkacem et al. MOLECULAR CANCER THERAPEUTICS
- Regorafenib Effects on Human Colon Carcinoma Xenografts Monitored by Dynamic Contrast-Enhanced Computed Tomography with Immunohistochemical Validation
- (2013) Clemens C. Cyran et al. PLoS One
- Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: Growth inhibition, quiescence, and recovery
- (2012) Brian I. Carr et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Effects of low concentrations of Regorafenib and Sorafenib on human HCC cell AFP, migration, invasion, and growth in vitro
- (2012) Brian I. Carr et al. JOURNAL OF CELLULAR PHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now